Cargando…

Network-based stage-specific drug repurposing for Alzheimer’s disease

Alzheimer’s disease (AD) is a progressive neurodegenerative disease and the most common type of dementia. With no disease-curing drugs available and an ever-growing AD-related healthcare burden, novel approaches for identifying therapies are needed. In this work, we propose stage-specific candidate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Savva, Kyriaki, Zachariou, Margarita, Bourdakou, Marilena M., Dietis, Nikolas, Spyrou, George M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Research Network of Computational and Structural Biotechnology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8957022/ https://www.ncbi.nlm.nih.gov/pubmed/35386099 http://dx.doi.org/10.1016/j.csbj.2022.03.013

Ejemplares similares

Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer’s Disease
por: Savva, Kyriaki, et al.
Publicado: (2023)

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19
por: Tomazou, Marios, et al.
Publicado: (2021)

Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood
por: Bourdakou, Marilena M., et al.
Publicado: (2023)

Vir2Drug: a drug repurposing framework based on protein similarities between pathogens
por: Minadakis, George, et al.
Publicado: (2022)

Systems Bioinformatics: increasing precision of computational diagnostics and therapeutics through network-based approaches
por: Oulas, Anastasis, et al.
Publicado: (2017)

Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains
por: Oulas, Anastasis, et al.
Publicado: (2021)

PathWalks: identifying pathway communities using a disease-related map of integrated information
por: Karatzas, Evangelos, et al.
Publicado: (2020)

Informed walks: whispering hints to gene hunters inside networks’ jungle
por: Bourdakou, Marilena M., et al.
Publicado: (2017)

Drug repurposing in idiopathic pulmonary fibrosis filtered by a bioinformatics-derived composite score
por: Karatzas, E., et al.
Publicado: (2017)

Discovering gene re-ranking efficiency and conserved gene-gene relationships derived from gene co-expression network analysis on breast cancer data
por: Bourdakou, Marilena M., et al.
Publicado: (2016)

Selecting variants of unknown significance through network-based gene-association significantly improves risk prediction for disease-control cohorts
por: Oulas, Anastasis, et al.
Publicado: (2019)

GeneStoryTeller: a mobile app for quick and comprehensive information retrieval of human genes
por: Eleftheriou, Stergiani V., et al.
Publicado: (2015)

Bacterial Wars—a tool for the prediction of bacterial predominance based on network analysis measures
por: Oulas, Anastasis, et al.
Publicado: (2023)

PathwayConnector: finding complementary pathways to enhance functional analysis
por: Minadakis, George, et al.
Publicado: (2019)

Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network
por: Soleimani Zakeri, Negar Sadat, et al.
Publicado: (2021)

Repurposing of Tibolone in Alzheimer’s Disease
por: Barreto, George E.
Publicado: (2023)

A Web-based database of genetic association studies in cutaneous melanoma enhanced with network-driven data exploration tools
por: Athanasiadis, Emmanouil I., et al.
Publicado: (2014)

In silico repurposing of antipsychotic drugs for Alzheimer’s disease
por: Kumar, Shivani, et al.
Publicado: (2017)

Machine learning identifies candidates for drug repurposing in Alzheimer’s disease
por: Rodriguez, Steve, et al.
Publicado: (2021)

Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
por: Araki, Wataru
Publicado: (2013)

Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2020)

Repurposing Licensed Drugs for Use Against Alzheimer’s Disease
por: Norins, Leslie C.
Publicado: (2021)

Single-cell-led drug repurposing for Alzheimer’s disease
por: Parolo, Silvia, et al.
Publicado: (2023)

Fibrotic expression profile analysis reveals repurposed drugs with potential anti-fibrotic mode of action
por: Karatzas, Evangelos, et al.
Publicado: (2021)

ChemBioServer 2.0: an advanced web server for filtering, clustering and networking of chemical compounds facilitating both drug discovery and repurposing
por: Karatzas, Evangelos, et al.
Publicado: (2020)

Repurposing Diabetes Drugs for Brain Insulin Resistance in Alzheimer Disease
por: Yarchoan, Mark, et al.
Publicado: (2014)

Anticancer drugs repurposed for Alzheimer’s disease: a systematic review
por: Ancidoni, Antonio, et al.
Publicado: (2021)

Correction: Repurposed agents in the Alzheimer’s disease drug development pipeline
por: Bauzon, Justin, et al.
Publicado: (2023)

Modeling Path Importance for Effective Alzheimer’s Disease Drug Repurposing
por: Xiang, Shunian, et al.
Publicado: (2023)

Repurposing antihypertensive drugs for the prevention of Alzheimer’s disease: a Mendelian randomization study
por: Walker, Venexia M, et al.
Publicado: (2019)

Drug repurposing with network reinforcement
por: Nam, Yonghyun, et al.
Publicado: (2019)

Targeting abnormal metabolism in Alzheimer's disease: The Drug Repurposing for Effective Alzheimer's Medicines (DREAM) study
por: Desai, Rishi J., et al.
Publicado: (2020)

Synthesize heterogeneous biological knowledge via representation learning for Alzheimer’s disease drug repurposing
por: Hsieh, Kang-Lin, et al.
Publicado: (2022)

Putative Antimicrobial Peptides Within Bacterial Proteomes Affect Bacterial Predominance: A Network Analysis Perspective
por: Oulas, Anastasis, et al.
Publicado: (2021)

Systematic identification of risk factors and drug repurposing options for Alzheimer's disease
por: Wu, Chong, et al.
Publicado: (2021)

Drug repurposing using meta-analysis of gene expression in Alzheimer’s disease
por: Jang, Ha Young, et al.
Publicado: (2022)

Investigating the Transition of Pre-Symptomatic to Symptomatic Huntington’s Disease Status Based on Omics Data
por: Christodoulou, Christiana C., et al.
Publicado: (2020)

Hybrid neural network approaches to predict drug–target binding affinity for drug repurposing: screening for potential leads for Alzheimer’s disease
por: Wu, Xialin, et al.
Publicado: (2023)

Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy
por: Chumakov, Ilya, et al.
Publicado: (2015)

Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer’s Disease: Using the Multiomics Approach
por: Advani, Dia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lctu8lpmlt2bco9d6njq45tfuf